SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-050739
Filing Date
2023-02-27
Accepted
2023-02-27 16:02:11
Documents
14
Period of Report
2023-02-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d455868d8k.htm   iXBRL 8-K 33918
2 EX-99.1 d455868dex991.htm EX-99.1 17239
6 GRAPHIC g455868im01.jpg GRAPHIC 3405
  Complete submission text file 0001193125-23-050739.txt   186849

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA lhdx-20230223.xsd EX-101.SCH 2866
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE lhdx-20230223_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lhdx-20230223_pre.xml EX-101.PRE 11269
8 EXTRACTED XBRL INSTANCE DOCUMENT d455868d8k_htm.xml XML 3340
Mailing Address 1315 63RD STREET EMERYVILLE CA 94608
Business Address 1315 63RD STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 23674655
SIC: 2835 In Vitro & In Vivo Diagnostic Substances